This post was written by Hetal Vig, MS, MGC, CGC, Director of Research and Clinical Engagement The 2024 NORD Breakthrough Summit focused on uniting leaders to...
Highlights from the 2024 NORD Breakthrough Summit
read more
Advocacy & Policy
Making Rare Cancer Day A Reality
This reflection was written by: Jim Palma, Chief Executive Officer Like many people in the rare cancer advocacy world, I entered my own advocacy work...
TCF Executive Director Jim Palma to Receive the 2022 Ruesch Center Luminary Award in GI Cancers
We are incredibly proud to announce that our Executive Director Jim Palma has been named a Ruesch Center 2022 Luminary Awards in GI Cancer recipient! The...
A Snapshot of a Special Volunteer
Meet TargetCancer volunteer Gleb Budilovsky! Gleb grew up in Topsfield, MA, and moved to Boston in 2005, where he lives with his wife Lindsey and adorable dog...
Meet Jenna Hart!
Meet TargetCancer Foundation volunteer Jenna Hart. Originally from Connecticut, Jenna now lives on Boston's North Shore and is the Senior Visual Designer on...
A Reflection of Purpose After 13 years: Remembering Our Founder
Written by Kristen Palma, TargetCancer Foundation President Each year, as I sit down to write this note, I wonder what more I can say. It has been 13...
Introducing Giselle Mota, our Newest Volunteer!
We are pleased to introduce you to TargetCancer Foundation's newest volunteer, Giselle Mota. Originally from Los Angeles, CA, Giselle currently resides in...
Introducing TCF Volunteer Catherine May
Originally from Dalton, MA, Catherine moved to the Boston area in 2020 after graduating from Williams College. She is a Senior Practice Coordinator at Mintz....
2022 Gala Volunteer Spotlight
As the 2022 TargetCancer Foundation Gala approaches, we are pleased to feature some of our wonderful volunteers, whose efforts are integral to the Gala's...
Promising New Cholangiocarcinoma Treatment Findings
An exciting paper was recently published in Cancer Discovery highlighting the promise of the recently FDA approved FGFR inhibitor drugs for an even broader...
10 Years Ago Today
Today TargetCancer Foundation remembers our founder, Paul Poth, whose life was taken by cholangiocarcinoma at age 39 on this day ten years ago- August 22,...
Teeing off for TargetCancer Foundation
By TargetCancer Foundation 2019 Summer Intern Ollie Cheever The fifth annual Matt Lindsay Memorial Golf Tournament tees off this Saturday, August 3rd, at the...
ASCO 2018: An Advocate’s Perspective
By TargetCancer Foundation Advocacy Council Chair Leslie Condon When I walked into McCormick Place on the first day of this year’s annual ASCO Conference, I...
Always Remember you Should be Heard: A Journey from Caregiver, to Patient, to Advocate
By Guest Blogger Dana Deighton Though my 25 years of professional experiences are mostly rooted in marketing, the last 15 years or so of my personal life have...
Considering Whether Criteria for Clinical Trials Exclude Too Many Patients
Clinical trials are a critical part of the development of new treatments. They rely on people who volunteer to participate and are then closely monitored by...